RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 128 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.27 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,712,435 | +120.1% | 406,662 | +154.4% | 0.02% | +142.9% |
| Q4 2022 | $1,232,312 | +3.8% | 159,833 | +43.3% | 0.01% | 0.0% |
| Q3 2022 | $1,187,000 | +521.5% | 111,575 | +376.7% | 0.01% | +600.0% |
| Q2 2022 | $191,000 | -69.9% | 23,408 | -73.6% | 0.00% | -80.0% |
| Q1 2022 | $635,000 | +9.7% | 88,748 | +162.7% | 0.01% | -16.7% |
| Q4 2021 | $579,000 | -9.1% | 33,777 | +22.0% | 0.01% | -25.0% |
| Q3 2021 | $637,000 | +28.4% | 27,686 | +103.6% | 0.01% | +33.3% |
| Q2 2021 | $496,000 | – | 13,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $26,790,000 | 44.35% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $50,694,446,000 | 9.21% |
| Samsara BioCapital, LLC | 775,583 | $28,309,000 | 3.50% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $55,088,000 | 3.17% |
| Laurion Capital Management LP | 3,858,617 | $140,839,000 | 0.78% |
| Casdin Capital, LLC | 548,156 | $20,008,000 | 0.51% |
| ALLEN OPERATIONS LLC | 68,104 | $2,486,000 | 0.43% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 472,552 | $17,248,000 | 0.40% |
| Ratan Capital Management LP | 110,000 | $4,015,000 | 0.35% |
| Comprehensive Financial Management LLC | 1,109,395 | $40,493,000 | 0.34% |